Loading clinical trials...
Loading clinical trials...
A Phase 2, Randomized, Parallel Group, Multi Center, Multi National Study for the Evaluation of Safety of Four Fixed Dose Regimens of DU-176b in Subjects With Non- Valvular Atrial Fibrillation
Conditions
Interventions
Edoxaban (DU-176b)
Edoxaban (DU-176b)
+3 more
Locations
91
United States
Huntsville, Alabama, United States
Anaheim, California, United States
Beverly Hills, California, United States
Stockton, California, United States
Orlando, Florida, United States
Sarasota, Florida, United States
Start Date
June 1, 2007
Primary Completion Date
June 1, 2008
Completion Date
June 1, 2008
Last Updated
February 26, 2019
NCT05147792
NCT06935591
NCT06189313
NCT05963698
NCT07015905
NCT03546374
Lead Sponsor
Daiichi Sankyo
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions